Arsenic sulphide As4S4 nanoparticles: Physico
Arsenic Disruption of DNA Damage Responses—Potential Role in
Arsenic Compounds as Therapeutic Agents
Arsenic and selenium toxicity and their interactive effects in humans
ARROCase Resectable Locally Advanced (Stage IIIA N2) Non
ARRO Case Inflammatory Breast Cancer
Around-the-Clock (ATC) Dosing of Analgesics
aromatase inhibitors as adjuvant therapy for post
AROMASIN (exemestane tablets) ADJUVANT CLINICAL
Aromasin (Breast Cancer) - Analysis and Forecasts to 2020 Brochure
ARLTS1 to Prostate Cancer Susceptibility SANNA SILTANEN
Arizona handout - UB Dental Alumni Home
aristolochic acid- and ochratoxin a-dna adducts
Arina, A., O. Murillo, S. Hervas-Stubbs, A. Azpilikueta, J. Dubrot, I. Tirapu, E. Huarte, C. Alfaro, J. L. Perez-Gracia, G. Gonzalez-Aseguinolaza, P. Sarobe, J. J. Lasarte, A. Jamieson, J. Prieto, D. H. Raulet, and I. Melero. 2007. The combined actions of NK and T lymphocytes are necessary to reject an EGFP+ mesenchymal tumor through mechanisms dependent on NKG2D and IFNgamma. Int J Cancer 121(6): 1282-195.
Arimidex’ (anastrozole): The Ideal Profile for an
ARIMIDEX® (anastrozole) in the Treatment of Early Breast Cancer
Arimidex (Breast Cancer) - Analysis and Forecasts to 2020 Brochure
